Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Telso AD_Sopharma_warrants_3years_EN_04.03.2026.pdfNotification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200001253

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 99 / 2026
Date of issue: 2026-03-06
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200001253
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200001253
Annexes
File Description
Telso AD_Sopharma_warrants_3years_EN_04.03.2026.pdf
Telso AD_Sopharma_warrants_3years_EN_04.03.2026.pdf		 Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200001253

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-03-06 Ognian Ivanov Donev Executive Director
20260306_145042_1466723926_Telso_AD_Sopharma_warrants_3years_EN_04.03.2026.pdf

Pobierz